ZEUS Gaining SARMs Blend 30 mg x 60 Capsules

Description

ZEUS Gaining SARMs Blend is a premium multi-compound research formulation combining MK-677 (Ibutamoren), LGD-4033 (Ligandrol), and RAD-140 (Testolone) into a single advanced investigational blend. Developed exclusively for laboratory research, this formulation enables researchers to investigate growth hormone secretagogue receptor activity, androgen receptor signaling, protein metabolism, endocrine physiology, and molecular endocrinology through complementary biological mechanisms.

By combining a Growth Hormone Secretagogue Receptor (GHS-R1a) agonist with two extensively researched Selective Androgen Receptor Modulators (SARMs), ZEUS Gaining SARMs Blend provides a comprehensive platform for studying growth hormone physiology, IGF-1 regulation, androgen receptor activation, gene transcription, receptor pharmacology, intracellular signaling, and musculoskeletal biology.

Each bottle contains 60 capsules, with MK-677 (Ibutamoren) 15 mg, LGD-4033 (Ligandrol) 5 mg, and RAD-140 (Testolone) 10 mg per capsule, providing a total active concentration of 30 mg per capsule. Manufactured under stringent pharmaceutical-quality standards, every batch undergoes comprehensive quality testing to ensure exceptional purity, formulation consistency, and dependable laboratory performance.

Key Features

• Premium multi-compound research formulation
• 60 capsules per bottle
• MK-677 (Ibutamoren) – 15 mg per capsule
• LGD-4033 (Ligandrol) – 5 mg per capsule
• RAD-140 (Testolone) – 10 mg per capsule
• Total active concentration: 30 mg per capsule
• Combines a Growth Hormone Secretagogue Receptor agonist with two investigational SARMs
• High-purity laboratory-grade formulation
• Suitable for investigations involving growth hormone physiology, androgen receptor biology, IGF-1 regulation, protein metabolism, receptor pharmacology, intracellular signaling, musculoskeletal physiology, and molecular endocrinology
• Manufactured under rigorous pharmaceutical-quality standards
• Intended exclusively for laboratory and scientific research applications

How It Works

ZEUS Gaining SARMs Blend combines three investigational compounds with complementary biological mechanisms, allowing researchers to investigate multiple molecular pathways within a single laboratory model.

• MK-677 (Ibutamoren) – 15 mg selectively activates the Growth Hormone Secretagogue Receptor (GHS-R1a), making it valuable for studies involving growth hormone secretion, ghrelin receptor signaling, IGF-1 physiology, endocrine regulation, and metabolic signaling.
• LGD-4033 (Ligandrol) – 5 mg selectively binds to the androgen receptor (AR), enabling investigations into protein metabolism, skeletal muscle physiology, receptor-ligand interactions, gene transcription, and intracellular signaling.
• RAD-140 (Testolone) – 10 mg selectively targets the androgen receptor (AR) and is extensively researched for androgen receptor activation, receptor pharmacology, protein metabolism, cellular differentiation, and molecular signaling.

Together, these complementary mechanisms provide researchers with a comprehensive platform for investigating growth hormone biology, IGF-1 regulation, androgen receptor signaling, protein metabolism, receptor pharmacology, cellular communication, musculoskeletal physiology, and molecular endocrinology.

This formulation is intended exclusively for laboratory and scientific research and is not intended for human consumption.

Contents

Active Ingredients (Per Capsule):

• MK-677 (Ibutamoren) – 15 mg
• LGD-4033 (Ligandrol) – 5 mg
• RAD-140 (Testolone) – 10 mg

Total Active Concentration: 30 mg per Capsule

Packaging: 60 Capsules